These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 2150910

  • 1. T-cell vaccination in experimental myasthenia gravis: a double-edged sword.
    Kahn CR, McIntosh KR, Drachman DB.
    J Autoimmun; 1990 Dec; 3(6):659-69. PubMed ID: 2150910
    [Abstract] [Full Text] [Related]

  • 2. Immunosuppression and induction of anergy by CTLA4Ig in vitro: effects on cellular and antibody responses of lymphocytes from rats with experimental autoimmune myasthenia gravis.
    McIntosh KR, Linsley PS, Drachman DB.
    Cell Immunol; 1995 Nov; 166(1):103-12. PubMed ID: 7585970
    [Abstract] [Full Text] [Related]

  • 3. Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG).
    Ma CG, Zhang GX, Xiao BG, Link H.
    Clin Exp Immunol; 1996 Jun; 104(3):509-16. PubMed ID: 9099937
    [Abstract] [Full Text] [Related]

  • 4. Nasal tolerance to experimental autoimmune myasthenia gravis: tolerance reversal by nasal administration of minute amounts of interferon-gamma.
    Li HL, Shi FD, Bai XF, Huang YM, van der Meide PH, Xiao BG, Link H.
    Clin Immunol Immunopathol; 1998 Apr; 87(1):15-22. PubMed ID: 9576006
    [Abstract] [Full Text] [Related]

  • 5. Induction of suppressor cells specific for AChR in experimental autoimmune myasthenia gravis.
    McIntosh KR, Drachman DB.
    Science; 1986 Apr 18; 232(4748):401-3. PubMed ID: 2938256
    [Abstract] [Full Text] [Related]

  • 6. T-cell immunity to acetylcholine receptor and its subunits in Lewis rats over the course of experimental autoimmune myasthenia gravis.
    Wang ZY, Link H, Huang WX.
    Scand J Immunol; 1993 May 18; 37(5):615-22. PubMed ID: 7683442
    [Abstract] [Full Text] [Related]

  • 7. Suppression of development of experimental autoimmune myasthenia gravis with isogeneic monoclonal anti-idiotopic antibody.
    Agius MA, Richman DP.
    J Immunol; 1986 Oct 01; 137(7):2195-8. PubMed ID: 3489757
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals.
    Shi FD, Bai XF, Li HL, Huang YM, Van der Meide PH, Link H.
    Clin Exp Immunol; 1998 Mar 01; 111(3):506-12. PubMed ID: 9528890
    [Abstract] [Full Text] [Related]

  • 10. Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment.
    Pachner AR.
    Yale J Biol Med; 1987 Mar 01; 60(2):169-77. PubMed ID: 3495075
    [Abstract] [Full Text] [Related]

  • 11. T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY, Qiao J, Melms A, Link H.
    Cell Immunol; 1993 Dec 01; 152(2):394-404. PubMed ID: 8258147
    [Abstract] [Full Text] [Related]

  • 12. Depletion of CD8+ T cells suppresses the development of experimental autoimmune myasthenia gravis in Lewis rats.
    Zhang GX, Ma CG, Xiao BG, Bakhiet M, Link H, Olsson T.
    Eur J Immunol; 1995 May 01; 25(5):1191-8. PubMed ID: 7774622
    [Abstract] [Full Text] [Related]

  • 13. 'Split tolerance' induction by intrathymic injection of acetylcholine receptor in a rat model of autoimmune myasthenia gravis; implications for the design of specific immunotherapies.
    Ohtsuru I, Matsuo H, Fukudome T, Suenaga A, Tsujihata M, Nagataki S.
    Clin Exp Immunol; 1995 Dec 01; 102(3):462-7. PubMed ID: 8536358
    [Abstract] [Full Text] [Related]

  • 14. Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor.
    Ma CG, Zhang GX, Xiao BG, Link J, Olsson T, Link H.
    J Neuroimmunol; 1995 Apr 01; 58(1):51-60. PubMed ID: 7537280
    [Abstract] [Full Text] [Related]

  • 15. Monoclonal anti-idiotopic antibodies against myasthenia-inducing anti-acetylcholine receptor monoclonal antibodies. Preponderance of nonparatope-directed antibodies affecting antigen binding.
    Agius MA, Geannopoulos CJ, Fairclough RH, Richman DP.
    J Immunol; 1988 Jan 01; 140(1):62-8. PubMed ID: 3257231
    [Abstract] [Full Text] [Related]

  • 16. B cell autoimmunity to acetylcholine receptor and its subunits in Lewis rats over the course of experimental autoimmune myasthenia gravis.
    Wang ZY, Link H, Qiao J, Olsson T, Huang WX.
    J Neuroimmunol; 1993 Jun 01; 45(1-2):103-12. PubMed ID: 8331155
    [Abstract] [Full Text] [Related]

  • 17. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells.
    Duan RS, Adikari SB, Huang YM, Link H, Xiao BG.
    Neurobiol Dis; 2004 Jul 01; 16(2):461-7. PubMed ID: 15193302
    [Abstract] [Full Text] [Related]

  • 18. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides.
    Fujii Y, Lindstrom J.
    J Immunol; 1988 Mar 15; 140(6):1830-7. PubMed ID: 2450133
    [Abstract] [Full Text] [Related]

  • 19. Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis.
    Okumura S, McIntosh K, Drachman DB.
    Ann Neurol; 1994 Nov 15; 36(5):704-13. PubMed ID: 7979216
    [Abstract] [Full Text] [Related]

  • 20. Breakdown of tolerance to a self-peptide of acetylcholine receptor alpha-subunit induces experimental myasthenia gravis in rats.
    Baggi F, Annoni A, Ubiali F, Milani M, Longhi R, Scaioli W, Cornelio F, Mantegazza R, Antozzi C.
    J Immunol; 2004 Feb 15; 172(4):2697-703. PubMed ID: 14764745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.